{"id":595940,"date":"2026-02-13T06:38:44","date_gmt":"2026-02-13T12:38:44","guid":{"rendered":"https:\/\/cerebrodigital.net\/?p=595940"},"modified":"2026-02-13T07:56:29","modified_gmt":"2026-02-13T13:56:29","slug":"polylaminin-breakthrough-spinal-cord-injury","status":"publish","type":"post","link":"https:\/\/cerebrodigital.net\/en\/polylaminin-breakthrough-spinal-cord-injury\/","title":{"rendered":"Polylaminin: the Brazilian breakthrough that could revolutionize spinal cord injury treatment"},"content":{"rendered":"\n

For decades, spinal cord injury<\/strong> has been one of the greatest challenges of modern medicine. Now, research led by biologist Tatiana Coelho Sampaio from the Federal University of Rio de Janeiro (UFRJ) introduces a possible therapeutic alternative based on polylaminin, an experimental protein that has shown promising preliminary results in patients with severe spinal cord damage.<\/p>\n\n\n\n

\"-\"<\/figure>\n\n\n\n

+<\/p>\n\n\n\n

What is polylaminin and how does it act in spinal cord injury?<\/strong><\/h2>\n\n\n\n

Polylaminin is an experimental protein developed from laminin, a key component of the extracellular matrix involved in the development of the nervous system. During the embryonic stage, laminin plays an essential role: it organizes and guides the formation of neuronal connections. However, in adulthood its presence decreases considerably, which limits the natural capacity for nervous tissue regeneration after <\/strong>a spinal cord injury.<\/p>\n\n\n\n

Based on more than 30 years of research in neuroscience and cell biology, the scientific team managed to develop a polymerized version of this protein. The goal is to recreate a favorable biological<\/a> environment to stimulate the reorganization of damaged nerve fibers.<\/p>\n\n\n\n

Polylaminin is applied directly to the affected<\/strong> area during surgical procedures. Its function is to act as a \u201cbiological scaffold\u201d that facilitates neuronal reconnection and promotes motor recovery. The compound is produced under pharmaceutical standards and is patent-protected, marking an important step toward clinical validation.<\/p>\n\n\n\n

\"-\"<\/figure>\n\n\n\n

Preliminary clinical results in patients with spinal cord injury<\/strong><\/h2>\n\n\n\n

International interest in polylaminin grew after reports of motor recovery in patients with severe spinal cord injuries. According to institutional reports, experimental applications were carried out in a small group of people, with varying degrees of functional improvement observed.<\/p>\n\n\n\n

One of the most notable cases describes progressive recovery of movement, eventually leading to the ability to walk again after the surgical procedure and subsequent rehabilitation. Although these results are encouraging, they are part of an initial study phase with limited scope.<\/p>\n\n\n\n

Currently, the Brazilian regulatory authority Anvisa has authorized the start of the first formal phase of human clinical trials. This stage focuses on evaluating the safety and possible adverse effects of the treatment, an essential requirement before expanding its application.<\/p>\n\n\n\n

Regenerative medicine and the future of paralysis treatment<\/h2>\n\n\n\n

The development of polylaminin falls within the field of regenerative medicine, but with a different approach compared to other therapies under investigation, such as those based on stem cells. Instead of introducing new cells, this strategy seeks to create structural conditions that allow the body itself to reorganize damaged nervous tissue.<\/p>\n\n\n\n

This approach could offer advantages in terms of standardization, production, and eventual integration into healthcare systems. In addition, researchers plan to evaluate its application in chronic spinal cord injuries, which would expand its potential therapeutic impact.<\/p>\n\n\n\n

If the upcoming clinical phases confirm the efficacy observed in preliminary studies, polylaminin could transform the treatment of spinal cord injury and position Brazil as a leader in biomedical innovation. However, the true scope of this breakthrough will depend on the scientific evidence built in the coming years.<\/p>\n\n\n\n

Polylaminin represents one of the most promising lines of research in the field of spinal cord injury treatment. Although it is still in the experimental phase, its initial clinical results suggest significant potential for motor recovery. The confirmation of its efficacy will depend on broader, more rigorous, and controlled clinical trials, which will determine its future in regenerative medicine.<\/p>\n\n\n\n

Reference:<\/p>\n\n\n\n

Polilaminina: Anvisa aprova in\u00edcio dos testes com pacientes com les\u00e3o medular.Link<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

For decades, spinal cord injury has been one of the greatest challenges of modern medicine. Now, research led by biologist […]<\/p>\n","protected":false},"author":2284,"featured_media":595938,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"two_page_speed":[],"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[],"tags":[107185],"class_list":["post-595940","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-science"],"jetpack_featured_media_url":"https:\/\/cerebrodigital.net\/wp-content\/uploads\/2026\/02\/image-76.png","jetpack_sharing_enabled":true,"jetpack_likes_enabled":false,"jetpack_shortlink":"https:\/\/wp.me\/pdR79Q-2v1W","jetpack-related-posts":[{"id":597113,"url":"https:\/\/cerebrodigital.net\/en\/new-drug-restores-movement-to-spinal-cord-injury-patients\/","url_meta":{"origin":595940,"position":0},"title":"New Drug Restores Movement to Spinal Cord Injury Patients","author":"Erick Sumoza","date":"September 19, 2025","format":false,"excerpt":"A team of Brazilian scientists from the\u00a0Federal University of Rio de Janeiro\u00a0has developed a drug that restores mobility to patients with spinal cord injuries. Based on poly-laminin, a protein extracted from the placenta, this advance is the result of more than 25 years of research. Although it still needs to\u2026","rel":"","context":"In "News"","block_context":{"text":"News","link":"https:\/\/cerebrodigital.net\/en\/category\/news-en\/"},"img":{"alt_text":"F\u00e1rmaco","src":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/09\/image-2025-09-19T230352.922.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/09\/image-2025-09-19T230352.922.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/09\/image-2025-09-19T230352.922.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/09\/image-2025-09-19T230352.922.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/09\/image-2025-09-19T230352.922.png?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":584852,"url":"https:\/\/cerebrodigital.net\/en\/chinas-brain-implants-paralyzed-patients\/","url_meta":{"origin":595940,"position":1},"title":"China’s Brain Implants Enable Paralyzed Patients to Walk Again","author":"Erick Sumoza","date":"June 16, 2025","format":false,"excerpt":"A clinical trial conducted in Shanghai has pushed the boundaries of neurological medicine with brain implants. Four patients paralyzed due to spinal cord injuries regained leg movement following an innovative surgery that reconfigures the nervous system without relying on robotic prosthetics. Chinese Brain Implants Outperform Neuralink\u2019s Surgery to place the\u2026","rel":"","context":"In "Ciencia"","block_context":{"text":"Ciencia","link":"https:\/\/cerebrodigital.net\/en\/category\/news-en\/ciencia-noticias-en\/"},"img":{"alt_text":"Los implantes cerebrales de China hacen que pacientes paralizados vuelvan a caminar","src":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/portada-30.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/portada-30.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/portada-30.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/portada-30.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/portada-30.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":596656,"url":"https:\/\/cerebrodigital.net\/en\/a-new-biological-key-to-autism-a-japanese-study-suggests-a-possible-prenatal-cause\/","url_meta":{"origin":595940,"position":2},"title":"A new biological key to autism: A Japanese study suggests a possible prenatal cause","author":"Erick Sumoza","date":"June 9, 2025","format":false,"excerpt":"A recent study by researchers at Fukui University in Japan has identified a possible link between certain fatty acids in umbilical cord blood and the development of autism spectrum disorder (ASD). This finding could mark a decisive advance in early diagnosis, understanding its biological causes, and potentially preventive measures during\u2026","rel":"","context":"In "Science"","block_context":{"text":"Science","link":"https:\/\/cerebrodigital.net\/en\/category\/science\/"},"img":{"alt_text":"Estudio","src":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/image-24.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/image-24.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/image-24.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/image-24.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2025\/06\/image-24.png?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":596269,"url":"https:\/\/cerebrodigital.net\/en\/doctors-remove-fetus-of-twin-from-1-year-old-girls-brain-in-extremely-rare-case\/","url_meta":{"origin":595940,"position":3},"title":"Doctors Remove Fetus of Twin from 1-Year-Old Girl’s Brain in Extremely Rare Case","author":"Erick Sumoza","date":"March 10, 2023","format":false,"excerpt":"En un caso extremadamente raro, los m\u00e9dicos extirparon quir\u00fargicamente un feto del cerebro de una ni\u00f1a de 1 a\u00f1o. Los m\u00e9dicos lo encontraron despu\u00e9s de que la ni\u00f1a mostrara un retraso en el desarrollo de las habilidades motoras, una circunferencia de la cabeza agrandada y una acumulaci\u00f3n de l\u00edquido en\u2026","rel":"","context":"In "Ciencia"","block_context":{"text":"Ciencia","link":"https:\/\/cerebrodigital.net\/en\/category\/news-en\/ciencia-noticias-en\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/03\/feto_cerebro_niyo_kjhbv-bicubic.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/03\/feto_cerebro_niyo_kjhbv-bicubic.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/03\/feto_cerebro_niyo_kjhbv-bicubic.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/03\/feto_cerebro_niyo_kjhbv-bicubic.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/03\/feto_cerebro_niyo_kjhbv-bicubic.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":596424,"url":"https:\/\/cerebrodigital.net\/en\/the-immune-switch-of-pain-what-il-10-reveals-about-differences-between-men-and-women\/","url_meta":{"origin":595940,"position":4},"title":"The Immune \u201cSwitch\u201d of Pain: What IL-10 Reveals About Differences Between Men and Women","author":"Erick Sumoza","date":"February 26, 2026","format":false,"excerpt":"A study published in Science Immunology revealed that the duration of pain does not depend solely on the injury, but on how the immune system turns it off. The key lies in cells called monocytes and an anti-inflammatory molecule, IL-10, which shows differences between sexes. IL-10 and Monocytes: How the\u2026","rel":"","context":"In "Science"","block_context":{"text":"Science","link":"https:\/\/cerebrodigital.net\/en\/category\/science\/"},"img":{"alt_text":"El \u201cinterruptor inmunol\u00f3gico\u201d del dolor: lo que revela la IL-10 sobre las diferencias entre hombres y mujeres","src":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2026\/02\/image-130.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2026\/02\/image-130.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2026\/02\/image-130.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2026\/02\/image-130.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2026\/02\/image-130.png?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":544699,"url":"https:\/\/cerebrodigital.net\/en\/neuralink-obtains-permission-to-implant-brain-chips-in-humans-eacr\/","url_meta":{"origin":595940,"position":5},"title":"Neuralink obtains permission to implant brain chips in humans","author":"Andrey Robles","date":"September 19, 2023","format":false,"excerpt":"Neuralink, the brain-chip startup founded by Elon Musk, has received approval to initiate its first human trial focusing on patients with paralysis caused by cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS). The trial was initially planned for 10 participants, but negotiations with the U.S. Food and Drug Administration\u2026","rel":"","context":"In "Ciencia"","block_context":{"text":"Ciencia","link":"https:\/\/cerebrodigital.net\/en\/category\/news-en\/ciencia-noticias-en\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/09\/Neuralink_jkhg-bell.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/09\/Neuralink_jkhg-bell.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/09\/Neuralink_jkhg-bell.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/09\/Neuralink_jkhg-bell.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/cerebrodigital.net\/wp-content\/uploads\/2023\/09\/Neuralink_jkhg-bell.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/posts\/595940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/users\/2284"}],"replies":[{"embeddable":true,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/comments?post=595940"}],"version-history":[{"count":3,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/posts\/595940\/revisions"}],"predecessor-version":[{"id":595943,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/posts\/595940\/revisions\/595943"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/media\/595938"}],"wp:attachment":[{"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/media?parent=595940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/categories?post=595940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cerebrodigital.net\/en\/wp-json\/wp\/v2\/tags?post=595940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}